MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-24-2026
Danaher Corporation ROCE Ratio 2011-2026 | DHR
Annual ROCE Ratio Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.93 | 9.82 | 9.73 | 15.04 | 14.12 | 10.64 | 5.72 | 7.92 | 7.22 | 7.16 | 8.25 | 10.86 | 10.86 | 10.77 | 9.89 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 15.04 | 5.72 | 9.79 |
Quarterly ROCE Ratio Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.41 | 7.19 | 11.92 | 14.15 | 12.43 | 15.44 | 15.4 | 12.12 | 14.86 | 14.58 | 12.02 | 6.61 | 9.79 | 9.62 | 10.18 | 10.8 | 10.68 | 10.76 | 10.77 | 10.83 | 11.32 | 11.56 | 11.44 | 11.35 | 10.96 | 11.11 | 11.63 | 11.96 | 11.54 | 10.53 | 9.9 | 9.13 | 10.08 | 11.76 | 13.05 | 14.32 | 14.43 | 14.22 | 14.07 | 13.94 | 14.66 | 15.13 | 15.8 | 16.64 | 16.71 | 16.54 | 15.89 | 15.48 | 3.8 | 3.61 | 3.46 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 16.71 | 3.46 | 11.84 |
ROCE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M |  USA |
 |
Agilent Technologies
A
|
25.0 | $ 118.41 | -1.12 % | $ 36 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 19.13 | -6.98 % | $ 206 M |  China |
 |
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M |  Israel |
 |
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
-10.16 | $ 20.4 | 16.11 % | $ 1.09 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M |  Britain |
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | USA |
 |
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
-236.6 | $ 1.44 | 1.24 % | $ 1.92 M | USA |
 |
Castle Biosciences
CSTL
|
1.9 | $ 24.65 | 0.12 % | $ 685 M | USA |
 |
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
0.8 | $ 182.43 | 0.98 % | $ 9.04 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | USA |
 |
Interpace Biosciences
IDXG
|
18.26 | $ 2.2 | - | $ 9.73 M | USA |
 |
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-219.45 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-35.1 | $ 129.72 | -1.92 % | $ 20.6 B | USA |
 |
Fulgent Genetics
FLGT
|
-6.52 | $ 16.11 | -0.34 % | $ 487 M | USA |
 |
Guardant Health
GH
|
440.3 | $ 85.08 | 0.26 % | $ 10.7 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B |  Niderland |
 |
NeoGenomics
NEO
|
-9.11 | $ 8.57 | -1.32 % | $ 1.1 B | USA |
 |
Anixa Biosciences
ANIX
|
-77.18 | $ 2.88 | -1.7 % | $ 93.5 K | USA |
 |
Biomerica
BMRA
|
-125.14 | $ 2.12 | 0.47 % | $ 4.87 M | USA |
 |
Medpace Holdings
MEDP
|
116.53 | $ 527.68 | 1.76 % | $ 15.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 116.64 | 0.12 % | $ 9.62 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 268.68 | 0.67 % | $ 22.4 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
6.33 | $ 29.16 | 0.31 % | $ 20 B | Niderland |
 |
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | Israel |
 |
Celcuity
CELC
|
-171.24 | $ 123.38 | -0.08 % | $ 5.77 B | USA |
 |
Senseonics Holdings
SENS
|
-111.94 | $ 6.79 | -1.59 % | $ 283 M | USA |
 |
Myriad Genetics
MYGN
|
-105.22 | $ 5.12 | -1.35 % | $ 474 M | USA |
 |
Lantheus Holdings
LNTH
|
28.52 | $ 84.11 | 0.2 % | $ 5.68 B | USA |
 |
Soleno Therapeutics
SLNO
|
2.09 | $ 52.65 | 0.14 % | $ 2.68 B | USA |
 |
Neuronetics
STIM
|
-140.48 | $ 1.37 | -1.44 % | $ 90.4 M | USA |
 |
Neogen Corporation
NEOG
|
-51.22 | $ 9.36 | -0.64 % | $ 2.03 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 193.25 | 1.0 % | $ 21.5 B | USA |
 |
ENDRA Life Sciences
NDRA
|
-185.74 | $ 5.14 | - | $ 4.05 M | USA |
 |
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | USA |
 |
National Research Corporation
NRC
|
161.47 | $ 17.73 | -0.62 % | $ 397 M | USA |
 |
Thermo Fisher Scientific
TMO
|
14.5 | $ 524.62 | -1.3 % | $ 198 B | USA |